Steven D. Leach, MD, director of the Dartmouth-Hitchcock Norris Cotton Cancer Center and the Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer at the Geisel School of Medicine at Dartmouth, has been named a Fellow of the American Association for the Advancement of Science.
Post Tagged with: "cancer"
Geisel professor and surgeon Richard Barth, MD, teamed up with two Thayer engineers to dramatically improve the accuracy of breast cancer surgery.
A newly published collaborative national study finds that most women with two or three sites of cancer in a single breast can successfully complete breast conservation therapy rather than mastectomy.
Many discoveries now revolutionizing the prevention and treatment of cancer can be traced back to Dartmouth—including immunotherapies for solid tumors, the integration of palliative care with cancer care, and the identification of cancer risks from environmental toxins and behaviors.
Experiences such as working as a volunteer on medical mission trips to Honduras and practicing as an oncology nurse in Arizona helped Meghan Bullock ’20 decide that medical school was the right path for her.
Michael Sporn, MD, emeritus professor of pharmacology and toxicology, and medicine, is featured in Nature Index 2017 for his tremendous impact upon biomedical research and drug development.
Dartmouth-led research is in early phase drug discovery and finds promising therapeutic leads after targeting vulnerabilities in nervous system tumors, including glioblastoma.
More than $12 million over five years has been awarded for research collaboration to more precisely determine lung cancer risk and improve screening.
Physician and scientist Steven D. Leach, MD, has been selected as the new Director of the Norris Cotton Cancer Center. The appointment was announced today by Dr. Duane Compton, dean of the Geisel School of Medicine at Dartmouth, and Dr. James N. Weinstein, CEO and President of Dartmouth-Hitchcock.
Large study co-led by Geisel professor Christopher Amos, PhD, identified several new variants for lung cancer risk that will translate into improved understanding of the mechanisms involved in lung cancer risk.